Medexprim is the European provider of regulatory-grade Real-World Imaging Evidence for biopharma across the world, through a network of academic hospitals in Europe and global data partners.
Medexprim was founded in 2015 in Toulouse, France, by PACS and medical imaging IT solution expert Karine Seymour, with a mission: unleash medical imaging archives for research. We are headquartered in Toulouse, with offices in Paris, London and Boston.
We specialize in datasourcing complex datasets to combine Real-World Imaging Data (RWID) and strong analytics capabilities to generate regulatory-grade Real-World Evidence to biopharma, AI imaging companies and Diagnostic & prognostic software.
We are pioneering new ways to design and execute clinical trials yielding to new methods to dramatically reduce the associated time, cost, and risks.
Our services are used for patient recruitment, cohort optimization and patient stratification, biomarker developments or synthetic control arms for virtual or hybrid trials.
We also deliver consulting services to healthcare institutions and radiology practices to advise on the efficient, legal and secure exploitation and valorization of their imaging exams and contextual clinical data.
Romain Cazavan began his career at Générale de Santé and joined Siemens France in 2001 as Chief Financial Officer. In 2015, he joined AGFA Healthcare as CFO, where he participated in the signature of the renewal of the APHP contract. Since 2017, he has acted as Business Angel and Business Developer for Digital Health Startups. He holds a Master’s degree from ESSEC.
CIO - Founder
Karine Seymour brings 20 years of experience in managing PACS projects in France and in North America. She founded Medexprim in 2015. She holds an engineering degree from ENSTA, Paris, a Master of Applied Science in Electrical and Computer Engineering from the University of British Columbia and an Executive MBA (Summa Cum Laude) from Toulouse Business School.
VP Data & Partnerships BU
Nicolas Dubost brings 27 years of experience in management and business development in the medical imaging and medical devices fields, in Europe and North America. He is fluent in English, German and Italian. He holds an MBA from ESCP Business School and a German Diplom-Kauffman from the TU Berlin.